Investors & Media
What’s new.
Press releases
Press releases.
October 10th 2024
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
September 24th 2024
Immutep Receives A$3.6 million R&D Tax Incentive from French Government
Investor updates
Analyst reports
Analyst reports.
September 25th 2024
Canaccord Genuity - Upcoming FDA ODAC meeting puts mounting pressure on Keytruda; Buy, A$0.95 PT (Analyst: Elyse Shapiro)
September 19th 2024
Capital One - Head and Neck Expert Call – Key Takeaways; Reiterate OW; US$8 PT (Analyst: Naureen Quibria, PhD)
September 16th 2024